Editorial Comment to Interpreting International Real‐World Survival Outcomes After Avelumab First‐Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data
Soichiro Yoshida, Yasuhisa Fujii. Editorial Comment to Interpreting International Real‐World Survival Outcomes After Avelumab First‐Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data. // International Journal of Urology. – 2026. – DOI: 10.1111/iju.70729. – URL: https://onlinelibrary.wiley.com/doi/10.1111/iju.70729?af=R
Soichiro Yoshida & Yasuhisa Fujii (2026). Editorial Comment to Interpreting International Real‐World Survival Outcomes After Avelumab First‐Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data. International Journal of Urology. https://doi.org/10.1111/iju.70729
Soichiro Yoshida and Yasuhisa Fujii. “Editorial Comment to Interpreting International Real‐World Survival Outcomes After Avelumab First‐Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data.” International Journal of Urology, 2026. doi:10.1111/iju.70729.
@article{Yoshida2026,
title = {Editorial Comment to Interpreting International Real‐World Survival Outcomes After Avelumab First‐Line Maintenance in Advanced Urothelial Carcinoma: An RMST Analysis of Reconstructed Individual Patient Data},
author = {Yoshida, Soichiro and Fujii, Yasuhisa},
journal = {International Journal of Urology},
year = {2026},
doi = {10.1111/iju.70729},
url = {https://onlinelibrary.wiley.com/doi/10.1111/iju.70729?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...